rDNA-RFLP identification of Candida species in immunocompromised and seriously diseased patients

Area of Science:

• Medical Mycology
• Molecular Biology
• Infectious Diseases

Background:

• Candida species are opportunistic fungal pathogens causing significant infections in immunocompromised and seriously ill patients.
• Accurate identification of Candida species is crucial for effective treatment and infection control, especially in hospital settings.
• Traditional methods for Candida identification can be time-consuming and may lack specificity.

Purpose of the Study:

• To employ Polymerase Chain Reaction (PCR) and restriction enzyme analysis for rapid and specific identification of Candida species.
• To investigate the prevalence and species distribution of Candida isolates from various patient populations and sample types in Brazil.

Main Methods:

• Ribosomal DNA (rDNA) was amplified from 76 Candida isolates using PCR with ITS1-ITS4 primers.
• Amplified rDNA fragments (350-950 bp) were digested with eight restriction enzymes.
• Restriction fragment length polymorphism (RFLP) patterns were analyzed to differentiate Candida species.

Main Results:

• Species-specific restriction patterns were successfully generated, enabling differentiation of medically important Candida species.
• Candida albicans was the most frequent species overall, except in newborns and clinical laboratory samples.
• Candida parapsilosis was the predominant species identified in samples from newborns and the clinical laboratory.

Conclusions:

• PCR-based restriction fragment length polymorphism is a reliable and specific method for identifying Candida species.
• The study highlights variations in Candida species distribution across different patient groups and clinical settings.
• Understanding species prevalence is vital for guiding antifungal therapy and infection control strategies in vulnerable populations.